Palmeux (Paliperidone Palmitate)

Paliperidone palmitate, the active ingredient in Palme de, is a atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the maintenance treatment of schizophrenia in adults. GNH USA supplies Palmeux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Palmeux as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Palmeux is a long‑acting antipsychotic that works within the dopamine‑serotonin pathway to stabilise mood‑related symptoms in schizophrenia.

- Schizophrenia: Improves control of psychotic symptoms and reduces relapse risk. - Schizoaffective disorder: Helps maintain symptom stability over time. - Bipolar I disorder (maintenance): Contributes to mood‑stabilisation during the maintenance phase. - Acute‑phase